Aspen Neuroscience is a San Diego-based biotechnology company headed by Damian McDevitt, President and CEO. The first product in their clinical pipeline is an autologous neuron replacement therapy for sporadic Parkinson’s disease (ANPD001)
Aspen Neuroscience is a San Diego-based biotechnology company headed by Damian McDevitt, President and CEO. The first product in their clinical pipeline is an autologous neuron replacement therapy for sporadic Parkinson’s disease (ANPD001)